Renaissance Technologies (RenTech)'s MBX Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC (Rentech)) currently holds 32,644 shares of MBX Biosciences, Inc. (MBX) worth $1.03 M, representing 0.00% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Renaissance Technologies (RenTech) has initiated a new position in MBX, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s MBX Biosciences (MBX) Holding Value Over Time
Track share changes against reported price movement
Quarterly MBX Biosciences (MBX) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +32,644 | New Buy | 32,644 | $31.54 |
Renaissance Technologies (RenTech)'s MBX Biosciences Investment FAQs
Renaissance Technologies (RenTech) first purchased MBX Biosciences, Inc. (MBX) in Q4 2025, acquiring 32,644 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held MBX Biosciences, Inc. (MBX) for 1 quarters since Q4 2025.
Renaissance Technologies (RenTech)'s largest addition to MBX Biosciences, Inc. (MBX) was in Q4 2025, adding 32,644 shares worth $1.03 M.
According to the latest 13F filing for Q4 2025, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC (Rentech), owns 32,644 shares of MBX Biosciences, Inc. (MBX), valued at approximately $1.03 M.
As of the Q4 2025 filing, MBX Biosciences, Inc. (MBX) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in MBX Biosciences, Inc. (MBX) was 32,644 shares, as reported at the end of Q4 2025.